Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Aug;19(8):1730-1732.e2.
doi: 10.1016/j.cgh.2021.02.004. Epub 2021 Feb 4.

COVID-19 Vaccination Intent and Perceptions Among Patients With Inflammatory Bowel Diseases

Affiliations

COVID-19 Vaccination Intent and Perceptions Among Patients With Inflammatory Bowel Diseases

Rahul S Dalal et al. Clin Gastroenterol Hepatol. 2021 Aug.

Abstract

Patients with inflammatory bowel disease (IBD) develop coronavirus disease 2019 (COVID-19) at similar rates as the general population, and there was initial concern regarding potential for severe illness.1-4 Vaccinations were authorized for emergency use in the United States in December 2020 and aim to halt the spread of COVID-19. However, there are concerns that people will be hesitant to receive the vaccine for a variety of reasons including insufficient data in certain populations including those with IBD. We surveyed patients with IBD to identify potential concerns regarding COVID-19 vaccination.

PubMed Disclaimer

References

    1. Brenner E.J., Ungaro R.C., Gearry R.B., et al. Corticosteroids, but not TNF antagonists, are associated with adverse COVID-19 outcomes in patients with inflammatory bowel diseases: results from an international registry. Gastroenterology. 2020;159:481–491. - PMC - PubMed
    1. Ungaro RC, Brenner EJ, Gearry RB, et al. Effect of IBD medications on COVID-19 outcomes: results from an international registry. Gut Oct 2020. . - DOI - PMC - PubMed
    1. Khan N, Patel D, Xie D, et al. Are patients with inflammatory bowel disease at an increased risk of developing SARS-CoV-2 than patients without inflammatory bowel disease? Results from a nationwide Veterans' Affairs cohort study. Am J Gastroenterol Oct 2020. . - DOI - PubMed
    1. Derikx LAAP, Lantinga MA, de Jong DJ, et al. Clinical outcomes of Covid-19 in patients with inflammatory bowel disease: a nationwide cohort study. J Crohns Colitis Oct 2020. . - DOI - PMC - PubMed
    1. Harris P.A., Taylor R., Minor B.L., et al. The REDCap consortium: building an international community of software platform partners. J Biomed Inform. 2019;95:103208. - PMC - PubMed

Substances